161 related articles for article (PubMed ID: 25093117)
1. Optimization of the Protocol for the Isolation and Refolding of the Extracellular Domain of HER2 Expressed in Escherichia coli.
Dolgikh VV; Senderskiy IV; Tetz GV; Tetz VV
Acta Naturae; 2014 Apr; 6(2):106-9. PubMed ID: 25093117
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of recombinant extracellular domain of human HER2 from Escherichia coli.
Liu X; He Z; Zhou M; Yang F; Lv H; Yu Y; Chen Z
Protein Expr Purif; 2007 Jun; 53(2):247-54. PubMed ID: 17257855
[TBL] [Abstract][Full Text] [Related]
3. Expression and Characterization of the Extracellular Domain of Human HER2 from Escherichia Coli, and Production of Polyclonal Antibodies Against the Recombinant Proteins.
Sun Y; Feng X; Qu J; Han W; Liu Z; Li X; Zou M; Zhen Y; Zhu J
Appl Biochem Biotechnol; 2015 Jun; 176(4):1029-43. PubMed ID: 25906688
[TBL] [Abstract][Full Text] [Related]
4. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
Panda AK
Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
[TBL] [Abstract][Full Text] [Related]
5. [Recombination of human HER2 gene encoding the extracellular domain and purification of fusion protein].
Liu X; He Z; Yang F; Yu Y; Lv H; Chen Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):136-41. PubMed ID: 16532828
[TBL] [Abstract][Full Text] [Related]
6. Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion.
Park S; Nguyen MQ; Ta HKK; Nguyen MT; Lee G; Kim CJ; Jang YJ; Choe H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204265
[TBL] [Abstract][Full Text] [Related]
7. Recombinant expression, purification and bioactivity characterization of extracellular domain of human tumor necrosis factor receptor 1.
Zhang C; Li A; Wang R; Cao Y; Jiang H; Ouyang S; Ma X; Lu Y
Protein Expr Purif; 2019 Mar; 155():21-26. PubMed ID: 30414969
[TBL] [Abstract][Full Text] [Related]
8. [On-column refolding and purification of human EGF receptor L2 domain inclusion body overexpressed in Escherichia coli].
Xu LH; Hong A; He XH
Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):597-603. PubMed ID: 16176099
[TBL] [Abstract][Full Text] [Related]
9. Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in
Hashemzadeh MS; Mohammadi M; Ghaleh HEG; Sharti M; Choopani A; Panda AK
Protein Pept Lett; 2021; 28(2):122-130. PubMed ID: 32729411
[TBL] [Abstract][Full Text] [Related]
10. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
[TBL] [Abstract][Full Text] [Related]
11. Optimization of a single-chain antibody fragment overexpression in Escherichia coli using response surface methodology.
Akbari V; Sadeghi HM; Jafarian-Dehkordi A; Chou CP; Abedi D
Res Pharm Sci; 2015; 10(1):75-83. PubMed ID: 26430460
[TBL] [Abstract][Full Text] [Related]
12. Penicillin-binding protein 2a of Streptococcus pneumoniae: expression in Escherichia coli and purification and refolding of inclusion bodies into a soluble and enzymatically active enzyme.
Zhao G; Meier TI; Hoskins J; Jaskunas SR
Protein Expr Purif; 1999 Jul; 16(2):331-9. PubMed ID: 10419829
[TBL] [Abstract][Full Text] [Related]
13. Obtaining and characterization of monoclonal antibodies against recombinant extracellular domain of human epidermal growth factor receptor 2.
Sarina N; Abeldenov S; Turgimbayeva A; Zhylkibayev A; Ramankulov Y; Khassenov B; Eskendirova S
Hum Antibodies; 2018 Feb; 26(2):103-111. PubMed ID: 29036807
[TBL] [Abstract][Full Text] [Related]
14. Expression and purification of HER2 extracellular domain proteins in Schneider2 insect cells.
Kanthala S; Mill CP; Riese DJ; Jaiswal M; Jois S
Protein Expr Purif; 2016 Sep; 125():26-33. PubMed ID: 26363121
[TBL] [Abstract][Full Text] [Related]
15. The mannosylated extracellular domain of Her2/neu produced in P. pastoris induces protective antitumor immunity.
Dimitriadis A; Gontinou C; Baxevanis CN; Mamalaki A
BMC Cancer; 2009 Oct; 9():386. PubMed ID: 19878568
[TBL] [Abstract][Full Text] [Related]
16. Optimized protocol for soluble prokaryotic expression, purification and refolding of the human inhibin α subunit, a cysteine rich peptide chain.
Kolivand S; Nazari M; Modarressi MH; Najafabadi MRH; Hemati A; Ghafouri-Fard S; Motevaseli E
Hum Antibodies; 2020; 28(2):131-139. PubMed ID: 31658054
[TBL] [Abstract][Full Text] [Related]
17. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
[TBL] [Abstract][Full Text] [Related]
18. Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab.
Todeschini P; Cocco E; Bellone S; Varughese J; Lin K; Carrara L; Guzzo F; Buza N; Hui P; Silasi DA; Ratner E; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Br J Cancer; 2011 Oct; 105(8):1176-82. PubMed ID: 21915118
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process.
Sarker A; Rathore AS; Gupta RD
Microb Cell Fact; 2019 Jan; 18(1):5. PubMed ID: 30642336
[TBL] [Abstract][Full Text] [Related]
20. Solvent extraction of recombinant interferon alpha-2b from inclusion bodies and efficient refolding at high protein concentrations.
Mousavi SB; Davarpanah SJ
Protein Expr Purif; 2022 Sep; 197():106110. PubMed ID: 35577182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
